Syneos Health, Inc.
SYNH · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Revenue | $1,366,080 | $1,356,800 | $1,359,867 | $1,336,223 |
| % Growth | 0.7% | -0.2% | 1.8% | – |
| Cost of Goods Sold | $1,071,363 | $1,088,549 | $1,041,703 | $1,017,784 |
| Gross Profit | $294,717 | $268,251 | $318,164 | $318,439 |
| % Margin | 21.6% | 19.8% | 23.4% | 23.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $182,523 | $161,517 | $137,693 | $130,355 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$841 | $61,587 | $62,242 | $61,514 |
| Operating Expenses | $241,855 | $223,104 | $199,935 | $191,869 |
| Operating Income | $42,221 | $35,784 | $94,855 | $117,843 |
| % Margin | 3.1% | 2.6% | 7% | 8.8% |
| Other Income/Exp. Net | -$41,560 | -$110,946 | -$54,151 | -$1,158 |
| Pre-Tax Income | $661 | -$75,162 | $40,704 | $116,685 |
| Tax Expense | -$132 | -$3,013 | -$14,824 | $29,636 |
| Net Income | $793 | -$72,149 | $55,528 | $87,049 |
| % Margin | 0.1% | -5.3% | 4.1% | 6.5% |
| EPS | 0.01 | -0.7 | 0.54 | 0.85 |
| % Growth | 101.4% | -229.6% | -36.5% | – |
| EPS Diluted | 0.01 | -0.7 | 0.54 | 0.84 |
| Weighted Avg Shares Out | 103,679 | 103,326 | 102,905 | 102,731 |
| Weighted Avg Shares Out Dil | 104,344 | 103,326 | 103,220 | 103,206 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,708 | $528 | $1,267 | $303 |
| Interest Expense | $37,877 | $26,259 | $25,132 | $22,131 |
| Depreciation & Amortization | $59,332 | $61,587 | $57,347 | $68,488 |
| EBITDA | $97,870 | $88,008 | $123,183 | $186,331 |
| % Margin | 7.2% | 6.5% | 9.1% | 13.9% |